Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Esthetic surgery complications can include infections, nerve injury, and more; proper evaluation and technique help prevent them.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

Polycystic Ovary Syndrome (PCOS) is not very common among Iranian women, but it's important to prevent it because of the risk of heart disease and infertility.

Altered metabolism can help control seizures by changing brain signaling and energy use, suggesting new treatments for epilepsy.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Placenta products might help with hair loss, but more research is needed.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

The document concludes that hair analysis is not good for assessing nutrition but can detect long-term heavy metal exposure.

Men with Type 2 Diabetes have lower DHT levels, which may affect fertility and lipid profiles.

Early diagnosis is crucial for treating alopecia effectively.

Anabolic steroids boost muscle growth, SARMs increase muscle mass and bone density without side effects, and myostatin inhibitors block a protein that stops muscle growth, but each has potential risks.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Girls with PCOS have higher levels of certain androgens, which are linked to excess hair growth, but these androgens don't help diagnose PCOS.

The Rotterdam Study aims to understand various diseases in older adults.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Hair aging is caused by stress, hormones, inflammation, and DNA damage affecting hair growth and color.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.